Literature DB >> 21076980

Design, synthesis and activity evaluation of mannose-based DC-SIGN antagonists.

Nataša Obermajer1, Sara Sattin, Cinzia Colombo, Michela Bruno, Urban Svajger, Marko Anderluh, Anna Bernardi.   

Abstract

In this article, we describe the design, synthesis and activity evaluation of glycomimetic DC-SIGN antagonists, that use a mannose residue to anchor to the protein carbohydrate recognition domain (CRD). The molecules were designed from the structure of the known pseudo-mannobioside antagonist 1, by including additional hydrophobic groups, which were expected to engage lipophilic areas of DC-SIGN CRD. The results demonstrate that the synthesized compounds potently inhibit DC-SIGN-mediated adhesion to mannan coated plates. Additionally, in silico docking studies were performed to rationalize the results and to suggest further optimization.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21076980      PMCID: PMC7089406          DOI: 10.1007/s11030-010-9285-y

Source DB:  PubMed          Journal:  Mol Divers        ISSN: 1381-1991            Impact factor:   2.943


The Below is the Electronic Supplementary Material. ESM 1 (DOC 917 kb) ESM 2 (PDF 898 kb)
  46 in total

1.  OriginPro 9.1: scientific data analysis and graphing software-software review.

Authors:  E Seifert
Journal:  J Chem Inf Model       Date:  2014-04-25       Impact factor: 4.956

2.  Leptospira interrogans is recognized through DC-SIGN and induces maturation and cytokine production by human dendritic cells.

Authors:  Narintorn Gaudart; Pattama Ekpo; Kovit Pattanapanyasat; Yvette van Kooyk; Anneke Engering
Journal:  FEMS Immunol Med Microbiol       Date:  2008-06-28

3.  Inhibition of DC-SIGN-mediated HIV infection by a linear trimannoside mimic in a tetravalent presentation.

Authors:  Sara Sattin; Anna Daghetti; Michel Thépaut; Angela Berzi; Macarena Sánchez-Navarro; Georges Tabarani; Javier Rojo; Franck Fieschi; Mario Clerici; Anna Bernardi
Journal:  ACS Chem Biol       Date:  2010-03-19       Impact factor: 5.100

4.  Low molecular weight antagonists of the myelin-associated glycoprotein: synthesis, docking, and biological evaluation.

Authors:  Stefanie Mesch; Delia Moser; Daniel S Strasser; Antje Kelm; Brian Cutting; Gianluca Rossato; Angelo Vedani; Hendrik Koliwer-Brandl; Matthias Wittwer; Said Rabbani; Oliver Schwardt; Soerge Kelm; Beat Ernst
Journal:  J Med Chem       Date:  2010-02-25       Impact factor: 7.446

5.  A comparative study of different glycosylation methods for the synthesis of D-mannopyranosides of Nalpha-fluorenylmethoxycarbonyl-trans-4-hydroxy-L-proline allyl ester.

Authors:  Dong Jun Lee; Renata Kowalczyk; Victoria J Muir; Phillip M Rendle; Margaret A Brimble
Journal:  Carbohydr Res       Date:  2007-08-29       Impact factor: 2.104

Review 6.  Interfering with the sugar code: design and synthesis of oligosaccharide mimics.

Authors:  Anna Bernardi; Pavel Cheshev
Journal:  Chemistry       Date:  2008       Impact factor: 5.236

7.  Niflumic acid renders dendritic cells tolerogenic and up-regulates inhibitory molecules ILT3 and ILT4.

Authors:  Urban Svajger; Alenka Vidmar; Matjaz Jeras
Journal:  Int Immunopharmacol       Date:  2008-04-01       Impact factor: 4.932

8.  Differential N-linked glycosylation of human immunodeficiency virus and Ebola virus envelope glycoproteins modulates interactions with DC-SIGN and DC-SIGNR.

Authors:  George Lin; Graham Simmons; Stefan Pöhlmann; Frédéric Baribaud; Houping Ni; George J Leslie; Beth S Haggarty; Paul Bates; Drew Weissman; James A Hoxie; Robert W Doms
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

Review 9.  Pathogen recognition by DC-SIGN shapes adaptive immunity.

Authors:  Teunis B H Geijtenbeek; Jeroen den Dunnen; Sonja I Gringhuis
Journal:  Future Microbiol       Date:  2009-09       Impact factor: 3.165

Review 10.  DC-SIGN and L-SIGN: the SIGNs for infection.

Authors:  Ui-Soon Khoo; Kelvin Y K Chan; Vera S F Chan; C L Steve Lin
Journal:  J Mol Med (Berl)       Date:  2008-05-06       Impact factor: 4.599

View more
  5 in total

1.  Comparative evaluation of several docking tools for docking small molecule ligands to DC-SIGN.

Authors:  Gregor Jug; Marko Anderluh; Tihomir Tomašič
Journal:  J Mol Model       Date:  2015-06-04       Impact factor: 1.810

2.  Drug-like Inhibitors of DC-SIGN Based on a Quinolone Scaffold.

Authors:  Hengxi Zhang; Ondřej Daněk; Dmytro Makarov; Stanislav Rádl; Dongyoon Kim; Jiří Ledvinka; Kristýna Vychodilová; Jan Hlaváč; Jonathan Lefèbre; Maxime Denis; Christoph Rademacher; Petra Ménová
Journal:  ACS Med Chem Lett       Date:  2022-05-10       Impact factor: 4.632

3.  On-Chip Screening of a Glycomimetic Library with C-Type Lectins Reveals Structural Features Responsible for Preferential Binding of Dectin-2 over DC-SIGN/R and Langerin.

Authors:  Laura Medve; Silvia Achilli; Sonia Serna; Fabio Zuccotto; Norbert Varga; Michel Thépaut; Monica Civera; Corinne Vivès; Franck Fieschi; Niels Reichardt; Anna Bernardi
Journal:  Chemistry       Date:  2018-09-03       Impact factor: 5.236

4.  Efficient synthesis of phenylene-ethynylene rods and their use as rigid spacers in divalent inhibitors.

Authors:  Francesca Pertici; Norbert Varga; Arnoud van Duijn; Matias Rey-Carrizo; Anna Bernardi; Roland J Pieters
Journal:  Beilstein J Org Chem       Date:  2013-01-31       Impact factor: 2.883

Review 5.  Molecular Recognition in C-Type Lectins: The Cases of DC-SIGN, Langerin, MGL, and L-Sectin.

Authors:  Pablo Valverde; J Daniel Martínez; F Javier Cañada; Ana Ardá; Jesús Jiménez-Barbero
Journal:  Chembiochem       Date:  2020-07-02       Impact factor: 3.461

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.